CINACALCET HYDROCHLORIDE | N021688 | AMGEN INC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2016-00085 | 7829595 | IPR | Complex Innovations, LLC | Institution Denied | 2015-10-26 | — |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Amgen Inc. v. Emcure Pharmaceuticals Ltd. et al 2 patentsANDA 210359cinacalcet hydrochloride | D. Del. | 2018-09-07 | Terminated 2018-12-07 | — |
Amgen Inc. v. Torrent Pharmaceuticals Ltd. et al 1 patentANDA 210781cinacalcet hydrochloride | D. Del. | 2017-12-22 | Terminated 2018-06-12 | — |
Amgen Inc. v. Watson Laboratories, Inc. et al 2 patentsANDA 202416cinacalcet hydrochloride | D. Del. | 2017-12-15 | Terminated 2018-02-12 | — |
| D. Del. | 2017-12-15 | Terminated 2018-02-12 | — | |
Amgen Inc. v. Breckenridge Pharmaceutical Inc. 1 patentANDA 207006cinacalcet hydrochloride | D. Del. | 2016-10-11 | Terminated 2017-09-21 | — |
| D. Del. | 2016-09-22 | Terminated 2017-09-20 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).